As shown in Table 4, the Ezh2 expression level was elevated in ESCC patients in line with WHO stage and predominantly up-regulated in late-stage tumor tissues (P=0.0221, P=0.0302, Figure 4B, Table 4). Here, EZH2 is linked to neoplasm.